Eben@CANSLIM ResearchSynopsys (SNPS) is trading in a Stage 4 decline, with the price below a falling 30-week moving average and failing all eight trend-template checks. The stock is 34.8% off its high and only 7.1% above its 52-week low, reflecting persistent weakness. The current 50-week base is deep at 39.2%, which carries an elevated failure rate and is flagged as faulty, with no VCP contraction sequence or breakout in sight. Overall sentiment is bearish, suggesting traders should avoid or take a defensive stance.
Technical Analysis
As of 2026-08-25 · Close $398.85
Stage Analysis
Stage 4 (Declining) — Price below a declining 30-week MA — downtrend (30-week MA 6-week slope: -3.43%)
Detected Patterns — What the Market Is Watching
- Deep Base (>33% — elevated failure rate) — depth 39.2%, length 50 weeks, pivot $612.17. Base formed from 2025-08-28 (left-side high) to 2026-08-25, with the low of $372.33 set on 2026-07-30
⚠️ Faulty cup warning: the base is 39.2% deep (above the 38–40% threshold). A correction this deep leaves heavy overhead supply — trapped holders from higher prices are likely to sell into any rally, raising the failure rate of a breakout from this base.
Subscribe to continue reading
Become a paid subscriber to get access to the rest of this post and other exclusive content.
